WNT-LRP5 Signaling Induces Warburg Effect through mTORC2 Activation during Osteoblast Differentiation

被引:308
作者
Esen, Emel [1 ,2 ]
Chen, Jianquan [1 ]
Karner, Courtney M. [1 ]
Okunade, Adewole L. [1 ,3 ]
Patterson, Bruce W. [1 ,3 ]
Long, Fanxin [1 ,2 ,4 ]
机构
[1] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Div Biol & Biomed Sci, St Louis, MO 63110 USA
[3] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA
关键词
BETA-CATENIN; BONE-FORMATION; PKC-DELTA; WNT; INSULIN; RICTOR; GLUCOSE; MICE; LRP5; GENE;
D O I
10.1016/j.cmet.2013.03.017
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
WNT signaling controls many biological processes including cell differentiation in metazoans. However, how WNT reprograms cell identity is not well understood. We have investigated the potential role of cellular metabolism in WNT-induced osteoblast differentiation. WNT3A induces aerobic glycolysis known as Warburg effect by increasing the level of key glycolytic enzymes. The metabolic regulation requires LRP5 but not beta-catenin and is mediated by mTORC2-AKT signaling downstream of RAC1. Suppressing WNT3A-induced metabolic enzymes impairs osteoblast differentiation in vitro. Deletion of Lrp5 in the mouse, which decreases postnatal bone mass, reduces mTORC2 activity and glycolytic enzymes in bone cells and lowers serum lactate levels. Conversely, mice expressing a mutant Lrp5 that causes high bone mass exhibit increased glycolysis in bone. Thus, WNT-LRP5 signaling promotes bone formation in part through direct reprogramming of glucose metabolism. Moreover, regulation of cellular metabolism may represent a general mechanism contributing to the wide-ranging functions of WNT proteins.
引用
收藏
页码:745 / 755
页数:11
相关论文
共 58 条
[1]   Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease [J].
Balemans, W ;
Patel, N ;
Ebeling, M ;
Van Hul, E ;
Wuyts, W ;
Lacza, C ;
Dioszegi, M ;
Dikkers, FG ;
Hildering, P ;
Willems, PJ ;
Verheij, JBGM ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
JOURNAL OF MEDICAL GENETICS, 2002, 39 (02) :91-97
[2]   Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST) [J].
Balemans, W ;
Ebeling, M ;
Patel, N ;
Van Hul, E ;
Olson, P ;
Dioszegi, M ;
Lacza, C ;
Wuyts, W ;
Van den Ende, J ;
Willems, P ;
Paes-Alves, AF ;
Hill, S ;
Bueno, M ;
Ramos, FJ ;
Tacconi, P ;
Dikkers, FG ;
Stratakis, C ;
Lindpaintner, K ;
Vickery, B ;
Foernzler, D ;
Van Hul, W .
HUMAN MOLECULAR GENETICS, 2001, 10 (05) :537-543
[3]   Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography [J].
Bouxsein, Mary L. ;
Boyd, Stephen K. ;
Christiansen, Blaine A. ;
Guldberg, Robert E. ;
Jepsen, Karl J. ;
Mueller, Ralph .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (07) :1468-1486
[4]   High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[5]   New targets of β-catenin signaling in the liver are involved in the glutamine metabolism [J].
Cadoret, A ;
Ovejero, C ;
Terris, B ;
Souil, E ;
Lévy, L ;
Lamers, WH ;
Kitajewski, J ;
Kahn, A ;
Perret, C .
ONCOGENE, 2002, 21 (54) :8293-8301
[6]   Proteomic analysis of β-catenin activation in mouse liver by DIGE analysis identifies glucose metabolism as a new target of the Wnt pathway [J].
Chafey, Philippe ;
Finzi, Laetitia ;
Boisgard, Raphael ;
Cauezac, Michele ;
Clary, Guillem ;
Broussard, Cedric ;
Pegorier, Jean-Paul ;
Guillonneau, Francois ;
Mayeux, Patrick ;
Camoin, Luc ;
Tavitian, Bertrand ;
Colnot, Sabine ;
Perret, Christine .
PROTEOMICS, 2009, 9 (15) :3889-3900
[7]  
Chen J, 2012, J BONE MINER RES
[8]   Metabolic changes in the glucose-induced apoptotic blastocyst suggest alterations in mitochondrial physiology [J].
Chi, MMY ;
Hoehn, A ;
Moley, KH .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2002, 283 (02) :E226-E232
[9]   Wnt/β-catenin signaling in development and disease [J].
Clevers, Hans .
CELL, 2006, 127 (03) :469-480
[10]  
Croce Jenifer C., 2008, V469, P3, DOI 10.1007/978-1-60327-469-2_1